Skip to main content

DCB Funding Opportunities

Funding Opportunity Announcements (FOA)

Title Announcement Number Opening Date Expiration Date Activity Code
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) RFA-CA-21-048 10/12/2021 10/20/2022 U54

Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-CA-21-049 10/12/2021 11/13/2021 U24
The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) PAR-21-348 11/15/2021 12/16/2023 U01
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention NOT-CA-21-121 10/04/2021 09/08/2024 N/A
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) PAR-21-322 09/05/2021 09/08/2024 R01
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) PAR-21-323 09/16/2021 09/08/2024 R21
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) PAR-21-324 09/16/2021 09/08/2024 R03
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards NOT-OD-20-055 03/05/2020 03/06/2023 N/A
Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Basic Mechanisms of Health Effects NOT-OD-21-127 06/28/2021 05/08/2023 N/A
Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) NOT-OD-21-092 06/28/2021 11/17/2023 R21
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) PAR-21-138 06/07/2021 12/02/2024 N/A
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-21-331 10/12/2021 09/08/2024 R01
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) PAR-21-332 10/18/2021 09/08/2024 R21
Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) RFA-CA-21-054 10/02/2021 11/03/2021 U54
Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed) RFA-CA-21-055 10/02/2021 11/03/2021 U24
Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia NOT-CA-21-057 05/06/2021 05/08/2023 N/A
Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) RFA-CA-21-041 10/01/2021 11/02/2021 U01
Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) RFA-CA-21-042 10/01/2021 11/02/2021 U24
Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed) RFA-CA-21-052 10/01/2021 11/02/2021 U54
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed) RFA-CA-21-053 10/01/2021 11/02/2021 U24
SBIR Program Solicitation: Therapeutics - Development of Senotherapeutic Agents for Cancer Treatment  PHS 2022-1 08/02/2021 10/28/2021 N/A
Reminder: NIH Natural Disaster Policy – Wildfires NOT-OD-20-176 09/25/2020 N/A N/A
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) PA-21-071 11/16/2020 05/08/2023 N/A
Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers NOT-CA-20-022 05/7/2020 01/08/2023 N/A
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) PAR-20-088 03/01/2020 04/02/2022 R01
Co-infection and Cancer (R21 Clinical Trial Not Allowed) PAR-20-061 02/17/2020 01/08/2023 R21
Co-infection and Cancer (R01 Clinical Trial Not Allowed)  PAR-20-062 02/06/2020 01/08/2023 R01
Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed) PAR-19-361 10/12/2019 03/12/2022 U01
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) PAR-19-353 09/21/2019 05/28/2022 R01
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) PAR-19-354 09/21/2019 05/28/2022 R21
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) PAR-19-287 05/22/2019 11/16/2021 U01
Microbial-based Cancer Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-19-193 05/05/2019 05/08/2022 R01
Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) PAR-19-194 05/16/2019 05/08/2022 R21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) PAR-19-199 05/10/2019 11/09/2021 R21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) PAR-19-198 05/10/2019 11/09/2021 R01
Biology of Bladder Cancer (R01 Clinical Trial Optional) PAR-19-183 05/05/2019 05/08/2022 R01
Biology of Bladder Cancer (R21 Clinical Trial Optional) PAR-19-184 05/16/2019 05/08/2022 R21
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) PAR-19-113 01/05/2019 01/08/2022 R01
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-20-131 05/05/2020 05/08/2023 R01